Posted On: 11/10/2012 7:06:22 AM
Post# of 72433
Why wouldn't they license just one compund at a time, while maintaining the rights to both the variations and the other compounds that address other diseases?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)